登录 | 注册    关注公众号  
微信公众号
搜索
 >  Antibody>IL-6 >FABr016-B

Biotinylated Monoclonal Anti-Mouse IL-6 Antibody, Rat IgG2a (AS543)

应用(Application)

Flow Cytometry.

特异性(Specificity)

This product is a specific antibody specifically reacts with mouse IL-6 protein.

免疫原(Immunogen)

Purified mouse IL-6 Protein.

偶联(Conjugate)

Biotin

制剂(Formulation)

Supplied as 0.2 μm filtered solution in PBS, pH7.4 with BSA as protectant.

Contact us for customized product form or formulation.

存储(Storage)

This product is stable after storage at:

  1. Store at 2° to 8°C.
  2. Do not use after the expiration date shown on the label.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 
评论(0)
 
ACRO质量管理体系
 
 

背景(Background)

Detection antibody for Multiplex Bead Assay.

 

前沿进展

Vildagliptin attenuates doxorubicin-induced hepatotoxicity via activating Nrf2/HO-1 and SIRT1 and suppressing NF-κB signals in rats
Mahmoud, Hassanein, Khalaf
Immunopharmacol Immunotoxicol (2025)
Abstract: Doxorubicin (DOX) is an anticancer commonly employed in cancer treatment. However, the clinical application of DOX is associated with hepatotoxicity. Vildagliptin is an anti-hyperglycemic agent that inhibits the dipeptidyl peptidase-4 enzyme. Besides being used in managing type-2 diabetes, vildagliptin showed potential anti-inflammatory, antioxidant, and other activities.Our investigation targeted the hepatoprotective effects of vildagliptin against DOX-induced hepatotoxicity.Vildagliptin was given in a dose of 30 mg/kg, once daily; p.o. for 2 weeks while DOX was injected in a single dose of 30 mg/kg, i.p.Vildagliptin effectively decreased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, while it effectively elevated serum total protein (TP) level. Histologically, vildagliptin administration resulted in significant hepatoprotective efficacy with abundant figures of normal hepatocytes. Moreover, vildagliptin considerably decreased lipid peroxidation biomarker malondialdehyde (MDA), and the cytokines interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), and cyclooxygenase (COX)-2, while it remarkably boosted the antioxidative defenses of glutathione (GSH) and catalase (CAT). Dual antioxidant and anti-inflammatory activities were mediated by upregulating nuclear factor (erythroid-derived 2)-like 2 (Nrf2), silent information regulator 1 (SIRT1), and heme oxygenase (HO-1) and suppressing the nuclear factor kappa B (NF-κB) signals. Finally, vildagliptin alleviated apoptosis by downregulating hepatic p53 and cytochrome (Cyt)-C.Our findings suggest that vildagliptin improved hepatocellular architecture and reduced hepatic oxidative injury, inflammation, and apoptosis associated with DOX treatment.
[Therapeutic effect of Huoxue prescription combined with extracorporeal shock wave on rotator cuff injury]
Zhu, Lou, Fei
Zhongguo Gu Shang (2025) 38 (3), 245-51
Abstract: To explore early clinical efficacy and advantages of Huoxue Fang's directional dialysis combined with extracorporeal shock wave in treating rotator cuff injury.A retrospective analysis was performed for 42 patients with rotator cuff injury admitted from September 2020 to December 2022, and they were divided into shock wave group and directed dialysis group according to different treatment methods. There were 20 patients in shock wave group, including 12 males and 8 females; aged from 47 to 68 years old with an average of (63.2±3.3) years old;the course of disease ranged from 2 to 6 weeks with an average of (3.1±1.4) weeks;10 patients with gradeⅠand 10 patients with gradeⅡaccording to Ellman classification;non-steroidal drugs and extracorporeal shock wave therapy were performed. There were 22 patients in directed dialysis group, including 16 males and 6 females;aged from 44 to 67 years old with an average of (61.0±2.3) years old;the course of disease ranged from 2 to 8 weeks with average of (3.3±1.3) weeks;12 patients with gradeⅠand 10 patients with gradeⅡaccording to Ellman classification;with Huoxue prescription directed transdrug therapy based on shock wave group. Visual analogue scale (VAS), University of California at Los Angeles (UCLA) and range of motion (ROM) were compared between two groups before treatment, 1 and 6 months after treatment;changes of tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6) between two groups were detected and compared. The complications between two groups were compared.All patients were followed up, shockwave group followed up for 6 to 8 months with an average of (7.1±1.9) months, 6 to 8 months with an average of (7.2±1.8) months in directed dialysis group, with no statistical significance between two groups (P>0.05). At 1 and 6 months after treatment, VAS in directed dialysis group were (3.85±0.99), (1.24±0.75), which were lower than that in shock wave group (4.91±0.89), (1.81±0.84) (P<0.05). UCLA scores in directed dialysis group (25.25±2.34), (32.71±2.33) were higher than those in shock wave group (21.67±3.38) °, (29.11±3.01) °(P<0.05). Forward bending (139.15±20.39) °, (150.14±20.55) °, external rotation (63.46±16.62) °, (73.35±13.82) °, internal rotation (46.99±2.93) °, (58.24±2.10) ° in directed dialysis group were better than those in shock wave group (130.61±22.27) °, (141.28±19.47) °, external rotation (57.36±17.53) °, (68.12±13.64) °, internal rotation (41.21±3.10) °, (49.16±3.21) ° (P<0.05). At 1 and 6 months after treatment, TNF-α, IL-1 and IL-6 in directed dialysis group were (2.12±0.49), (2.06±0.55), (0.69±0.26) μg·L-1;(1.27±0.25), (1.14±0.23), (0.37±0.11) μg·L-1, which were lower than those in shock wave group (2.87±0. 51), (2.67±0.48), (0.92±0.21) μg·L-1, (1.88 ± 0.26), (1.36±0.27), (0.45±0.09) μg·L-1(P<0.05). At the latest follow-up, 8 patients got excellent result, 10 good and 2 poor in shock wave group;10 patients excellent, 10 good, and 2 poor in directed dialysis group;there was no significant difference between two groups (P>0.05). There were no complications such as skin allergy, subcutaneous hemorrhage, ecchymosis, vascular and nerve injury occurred in both groups.For the treatment of rotator cuff injury, Huoxue prescription combined with extracorporeal shock wave is effective, which could not only release the local adhesion tissue, improve local blood circulation, accelerate absorption of inflammatory exudate of the local soft tissue, and promote recovery of the diseased muscle bond and ligament. It could also effectively relieve shoulder pain, improve shoulder motion, restore shoulder function, improve patients' quality of life.
Exploring the Potential of Lemon Peel Extracts in Cosmetics: Chemical Composition and Bioactive Properties
Huang, Xu, Liu et al
J Microbiol Biotechnol (2025) 35, e2412042
Abstract: In this study, the potential of lemon peel extracts as cosmetic raw materials was explored, with focus on their composition, aroma, antimicrobial, and other bioactivities. Lemon peel essential oil (LPEO), extract (LPE) and absolute oil (LPAO) were prepared by hydrodistillation and organic solvent extraction, respectively. GC/MS analysis indicated that LPEO, LPE, and LPAO contained 22, 39, and 9 components, respectively, with terpenoids being the predominant component. LPE had the highest total flavonoid content and exceeded the total phenolic content. LPEO demonstrated the strongest aroma intensity and persistence, as measured by electronic nose. All three lemon peel extracts showed good antioxidant, anti-tyrosinase, and antimicrobial properties, while inhibition rates exceeded 90% in the experimental concentration range in a dose-dependent manner. Although the antioxidant and antibacterial effects of LPAO were stronger than those of LPEO, the latter had better anti-tyrosinase action. LPEO also demonstrated superior anti-inflammatory effects, with inhibitory rates of 87.79 ± 3.86% and 80.75 ± 2.33% on TNF-α and IL-6 at 1 × 10-2 mg/ml. Moreover, LPEO promoted HaCaT cell migration better than LPE and LPAO, and the healing rate of scratched HaCaT cells treated with LPEO at 1 × 10-2 mg/ml for 12 h was 95.29 ± 3.41%. In addition to its antioxidant and antibacterial properties, the overall performance of LPEO was superior by comparison with LPE and LPAO. In summary, the three extracts can be combined to expand their application as skincare and cosmetic additives with aroma-improving, antioxidant, whitening, antibacterial, anti-inflammatory, and wound-healing activities.
Effect and Mechanism of Tricholoma matsutake Extract on UVA and UVB Radiation-Induced Skin Aging
Hu, Huang, Weng et al
J Microbiol Biotechnol (2025) 35, e2411085
Abstract: Ultraviolet (UV) radiation often causes skin aging, inflammation, cancer and other related skin diseases. In this study, the main components of Tricholoma matsutake extract (TME) were identified using UPLC-Q-TOF-MS, and their anti-photoaging effects were assessed through UV-induced cell and animal models. The key components identified were D-mannitol (27.41%), DL-malic acid (14%), alginate (12.5%), isoleucine (4.82%), and phenylalanine (4.31%), all of which played roles in anti-aging and UV protection. TME (50-100 mg/ml) significantly alleviated UVA/UVB-induced erythema and wrinkles in mice. Pathological staining showed that TME suppressed UV-induced epidermal hyperplasia (p < 0.05), reduced collagen damage (p < 0.01), and decreased mast cell infiltration (p < 0.01), while down-regulating inflammatory markers such as IL-6, IL-1β, and TNF-α. TME also upregulated type I collagen (COL-1). Flow cytometry results demonstrated that high-dose TME inhibited UV-induced apoptosis and reduced reactive oxygen species (ROS) in HaCaT cells (p < 0.05). Immunofluorescence and scratch migration assays showed that TME promoted PPAR-α expression, reduced inflammation, and supported skin repair (p < 0.01). Transcriptomic and metabolomic analyses indicated that TME regulated inflammation-related signaling pathways, helping to prevent skin aging. TME is a promising natural product for skin care and treatment of oxidative stress and inflammation-related diseases.
Showing 1-4 of 206571 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
IL-6靶点信息
英文全称:Interleukin-6
中文全称:白细胞介素-6
种类:Homo sapiens
上市药物数量:6详情
临床药物数量:22详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定